$13 million will fund a multidisciplinary, multi-institution team effort to develop stronger and more versatile vaccines
Not for public release
This news release is embargoed until 11-Sep-2023 5:00 PM EDT
Released to reporters: 5-Sep-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 11-Sep-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Dr. Weiping Zhang, professor in the Department of Pathobiology, was recently awarded a five-year, $5.6 million R01 grant from the National Institutes of Health (NIH) to optimize a promising vaccine against enterotoxigenic Escherichia coli (ETEC).
A new international study led by Queen Mary University of London has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination.
Tomar a vacina contra COVID-19 pode não só reduzir os riscos de uma pessoa contrair COVID de longa duração, mas também pode significar a redução dos sintomas para a pessoa que desenvolver a doença.
Recibir la vacuna contra la COVID-19 podría significar no solo un menor riesgo de tener síndrome crónico de COVID, sino también la presencia de menos síntomas para quienes contraigan la afección.
Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.
La Jolla Institute for Immunology (LJI) scientists have published a pair of studies that show how we might harness CD4+ T cells while boosting the cancer-fighting power of CD8+ "killer" T cells.
Researchers have determined how Leishmaniasis vaccine candidates, created using mutated disease-causing parasites, prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine.
Saad B. Omer, M.B.B.S., M.P.H., Ph.D., Founding Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center, discovered a passion for public health while he was a medical student in Pakistan.
SCALE-UP Counts was designed to promote COVID-19 testing in local schools. Huntsman Cancer Insitute’s Yelena Wu, PhD, hopes the insight gained from the program improves cancer screening and education initiatives.
High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study.
Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.
The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.
A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.
Rutgers scientists have devised a highly accurate method for creating coatings of biologically active materials for a variety of medical products. Such a technique could pave the way for a new era of transdermal medication, including shot-free vaccinations, the researchers said.
A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.
A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire(*1) has been developed by a research group.
The start of the school year can be tough for many children. For some, the struggle might last just a few days. For others, however, a difficult transition back to school might be a sign of an undetected behavioral or developmental condition that requires medical attention.
Before they had access to livestock vaccines, many women in rural parts of Africa who manage livestock had to resort to traditional medicines when their animals got sick, or suffer loss of their animals.
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.
Vaccinations, blood tests, or IVs – it’s fair to say that no child likes a needle. So, when it comes to the jab, a light touch and a caring approach is incredibly welcomed – both by the child and the parent. Now, world-first research from the University of South Australia shows that while many children suffer distress, new ultrasound-guided techniques could provide much-needed reprieve.
Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.
Over 50 million K-12 students across the United States will return to classrooms this month, according to the National Center for Education Statistics. Michigan State University experts provide guidance on how to ensure students are physically and mentally prepared for the new school year.
Madagascar is one of the poorest countries in the world and access to health care is limited for many people. A new study from the University of Illinois Urbana-Champaign examines the effectiveness of a health intervention program that enlists community-based health workers to promote child vaccination uptake.
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.
University of Adelaide researchers have started work on developing a new vaccine that could help ward off painful ear infections in children. The potential vaccine is in the initial stages of development in the lab and will target one of the main types of bacteria that cause middle ear infections, a common illness among infants and young children.
A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops COVID infection in both young and old mice.
Which types of personalities were more hesitant about COVID-19 vaccination during the pandemic’s peak? Extroverts — according to a new study on more than 40,000 Canadians.
The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn’t gone—and neither is the risk of getting the disease. For parents, navigating when to get their child vaccinated and knowing how to best protect their child from COVID-19 can be complicated. We spoke to Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control at Children’s Hospital Los Angeles, to get an update on the latest COVID-19 vaccine information and precautions.
Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies.
In a new study, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions of the whooping cough vaccine. The unexpected findings may help explain the recent rise in whooping cough cases and point to potential targets for the next generation of vaccines.